Global Bioprocessing Market Size: 14% CAGR to $72.55B by 2031

The Bioprocessing Market stands at the forefront of transforming healthcare through cutting-edge technologies that enable efficient production of biologics, vaccines, and advanced therapies. As demand surges for personalized medicines and cell therapies, industry leaders embrace automation, digital twins, and single-use systems to streamline operations and enhance scalability.​

This evolution reflects a broader shift toward sustainable, flexible manufacturing that meets global needs for high-quality biopharmaceuticals. Recent breakthroughs underscore how bioprocessing innovations drive reliability and speed in drug development.​

Key Market Insights by 2031

Global Market Size and Growth: The bioprocessing market expands steadily, fueled by upstream and downstream advancements, with projections showing significant scaling through single-use bioreactors and continuous processing.​

Market Share Leaders: Upstream products hold dominant share due to cell line optimization and high-density cultures, while single-use segments gain traction for flexibility in clinical and commercial operations.​

Emerging Trends: Automation via AI and machine learning optimizes real-time monitoring; perfusion systems boost cell densities; digital twins predict process outcomes for consistent yields.​

Forecast to 2031: Continued rise in cell and gene therapy applications propels growth, alongside modular platforms reducing downtime; sustainable materials address waste concerns in single-use tech.​

Global Analysis: North America leads with robust infrastructure for monoclonal antibodies and viral vectors; Europe emphasizes regulatory-compliant eco-friendly processes.​

Check valuable insights in the Bioprocessing Market report. You can easily get a sample PDF of the report - https://www.theinsightpartners.com/sample/TIPRE00039016

Regional Dynamics Shaping Bioprocessing

North America: Commands the largest presence through early adoption of AI-integrated bioreactors and high-throughput systems, supporting vast pipelines of biologics and CGT.​

U.S. hubs accelerate with nanofiber microcarriers and collaborative R&D for viral vector scaling.​

Asia Pacific: Fastest-growing region, driven by China’s state-backed biologics expansion and India’s biopharma parks adopting single-use workflows.​

Investments in flexible facilities position the area for modular manufacturing dominance by 2031.​

Europe: Focuses on purification efficiency and green bioprocessing, with Germany leading in automation and quality monitoring.​

Hybrid systems blend single- and multi-use for cost-effective scalability.​

Other Regions: Middle East & Africa build bioeconomy foundations via innovation zones; Latin America advances through partnerships.​

Market Driver

Increasing Prevalence of Chronic Diseases Propel Market Growth

The sedentary life of older people has boosted the prevalence of lifestyle disorders, such as obesity and diabetes. Inherited genes can also express these conditions along with other health concerns such as cardiovascular disease (CVDs), Alzheimer’s disease, and depression. As per the National Council on Aging, Inc., 80% of adults (aged 65 and more) are reported to suffer from at least one chronic condition in their lifetime. According to the Centers for Disease Control and Prevention (CDC), approximately 6 of 10 people in the US suffered from at least one serious disease, and 4 of 10 people had two or more chronic conditions in 2020.

CVDs, such as angina pectoris, atherosclerosis, and acute myocardial infarction caused because of hectic lifestyles, are among the significant causes of mortality across the world. As per the World Heart Foundation, mortality caused due to CVD has surged by 60% over the past 30 years (1990–2020). 20.5 million deaths were recorded in 2021 due to CVDs. Diabetes is one of the life-threatening chronic diseases with no functional cure. According to the International Diabetes Federation, the number of diabetic cases in North America is anticipated to grow from 46 million in 2017 to 62 million by 2045.

Key Player Analysis

Cytiva (Danaher Corporation), Sartorius AG, Thermo Fisher Scientific Inc., Repligen Corporation, Merck KgaA, 3M Company, Getinge AB, Eppendorf SE, Corning Incorporated, Entegris, Agilent Technologies, and Bio-Rad Laboratories are among the key players profiled in the bioprocessing market report.

Analyst Perspective:

The report includes growth prospects owing to the current bioprocessing market trends and their foreseeable impact during the forecast period. The growing cases of chronic diseases are one of the major factors increasing the demand for new drugs, which creates a need for bioprocessing. In addition, personalized treatment of diseases such as cancer increases the demand for various bioprocessing technologies, including cell therapy. The importance of research and development in the life sciences industry has been greatly promoted in recent years. Due to this trend, government support for the pharmaceutical and biotech industries is also increasing. Additionally, a growing focus on preventative measures and alternative medicines for specific applications drives the market for bioprocessing. Additionally, increasing investment in new technologies to overcome performance and quality issues associated with manufacturing bioprocess products is expected to drive bioprocessing market growth.

Future Outlook: Scalable, Green Bioprocessing

By 2031, bioprocessing integrates AI for predictive analytics, perfusion for density, and modular designs for agility. Small-scale surges for personalized meds; large-scale sustains blockbusters. Sustainability trends include biodegradable single-use and energy-efficient plants. Regions like Asia Pacific leapfrog with government incentives. These shifts promise faster therapies, lower risks, and global access.

Get Premium Research Report of Bioprocessing Market Size and Growth Report at: https://www.theinsightpartners.com/buy/TIPRE00039016

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.

Contact Us:

• If you have any queries about this report or if you would like further information, please get in touch with us:
• Contact Person: Ankit Mathur
• E-mail: ankit.mathur@theinsightpartners.com
• Phone: +1-646-491-9876
• Also Available in: Korean German Japanese French Chinese Italian Spanish